| Home | Log In | Register | Our Services | My Account | Contact | Help |
|
|
|
Gold
|
|
|
|
|
|
|
|
S&P &Futures (Click for latest) |
Pre Market Futures (7:30) | ||
| FTSE | + 2 | ||
| TechMark | + 1 | ||
| DAX | + 4 | ||
|
Hang Seng -96 |
Nikkei+48 |
DOW | - 46 |
| S&P | - 7 | ||
| Nasdaq | - 4.3 | ||
|
News Headlines:
Better than expected earnings helped the US indexes all finish in the blue yet again. Siemens like many other companies at the moment reported positive news with business says they were ontrack for 2003 earnings targets after posting a drop in second quarter profits and sales. The FTSE is expected to open flat but should soon slip into negative territory with weak US futures following the "Beige Book" report showing a flaky US economy with a drip in retail sales during the Iraq war. Persimmon says they build only a very small proportion of its homes within the M25. In the North we are seeing increased demand with further price growth. The forward sales will ensure that our first half expectations are met and have 170 million of sales value already contracted or reserved for the second half of the current year. Allied Domecq: Beats profits forecasts, they reported a two percent rise in half-year profits and said it was on track to meet current market expectations. They reported pre-tax profits of 256 million pounds for the six-month compared to forecasts of 240-254 million pounds. BP, SHEL OPEC prepared on Wednesday to cut back excess oil supply and shore up falling prices ahead of the return of Iraqi exports to the world market. Peacock may have to guide forecasts higher after a period of "stellar" sales growth
|
|||||||||||||||||
- 24 Apr 2003 09:04
- 3 of 3
| 22nd Apr | 23rd Apr | Change | Consensus Rating | Broker Change | |
| Allied Domecq | 2.61 | 2.83 | -8.4% | Hold | Ahead of tomorrow's interim results HSBC reiterates "reduce" rating as it believes the risks are on the downside, while DKW says "buy" but continues to prefer rival, Pernod Ricard |
| AstraZeneca | 2.43 | 2.44 | -0.4% | Outperform | Rating moves slightly ahead of Q1 figures out next week and on positive Q1 figures from US peer Eli Lilly |
| BHP Billiton | 2.45 | 2.5 | -2.0% | Outperform | Q3 trading report reveals a weak performance in oil and gas and a stronger than expected performance from mining assets, prompting a "reduce" rating from Investec |
| Friends Provident | 2.73 | 2.81 | -2.9% | Hold | Lehman initiates coverage with an "underweight" rating, as it believes that, without a recovery in equity markets, FP will find it tough to compete in the UK market |
| GlaxoSmithKline | 2.9 | 2.92 | -0.7% | Hold | Rating slips as BSCH and CDC Ixis reduce full year forecasts ahead of next week's Q1 results |
| Legal & General | 2.57 | 2.63 | -2.3% | Hold | Lehman initiates coverage with "underweight" rating, as the broker fears LGEN will use its capital strength to support an unsustainable dividend payment |
| Reuters | 3.6 | 3.6 | 0.0% | Underperform | Shares lift as the UK market, European media sector and the investment banking community rise. However in spite of being one of the main risers on the FTSE today its rating sticks |
| Sage | 2.97 | 3 | -1.0% | Hold | UBS downgrades to "neutral" as the broker highlights the negative underlying license momentum and the unimpressive organic growth rate of 2-3% |
| Scottish & Newcastle | 2.96 | 3 | -1.4% | Buy | Smith Barney points out that fears of a dividend cut will continue to hang on the shares until the cut is announced or until substantial cash flow improvements are seen |
| WPP | 3.04 | 3.04 | 0.0% | Hold | Williams says "hold" ahead of WPP's Q1 revenue figures on Friday. The broker expects revenue to be slightly down but the outlook to be brighter as improvements are seen in advertising market, but it adds the group will remain vulnerable to company specific problems |